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DObjective: To analyze the risk reduction of cardiopulmonary bypass complications between on-pump and
off-pump coronary artery bypass grafting in high-risk patients.
Methods: This multicenter, prospective, randomized, parallel trial enrolled patients for elective or urgent
isolated coronary artery bypass grafting with an additive European System for Cardiac Operative Risk
Evaluation of 6 or more. The patients in cardiogenic shock were excluded. The composite primary end
point included operative mortality, myocardial infarction, stroke, renal failure, reoperation for bleeding
and adult respiratory distress syndrome within 30 days after surgery. The total sample size was 693 pa-
tients, according to a scheduled interim analysis at 400 patients enrolled (a-spending ¼ 0.029, Pocock
method).
Results: A total of 411 patients were included in the interim analysis. Randomization assigned 203 patients to
on-pump and 208 patients to off-pump treatment. Of the 411 patients, 24 crossed over; thus, 195 patients were
actually treated on-pump and 216 off-pump. According to the intention to treat analysis, the rate of the compos-
ite primary end point was significantly lower (unadjusted P ¼ .009, adjusted P ¼ .010) in the off-pump group
(5.8% vs 13.3%). The risk of experiencing the primary end point was significantly greater for the on-pump
group (unadjusted odds ratio, 2.51; 95% confidence interval, 1.23–5.10; P ¼ .011; adjusted odds ratio, 3.07;
95% confidence interval, 1.32–7.14; P ¼ .009).
Conclusions: Off-pump coronary artery bypass grafting reduces early mortality and morbidity in high-risk
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The Journal of Thoracic and CaOff-pump coronary artery bypass grafting (CABG) was
introduced in the mid-1990s to reduce operative mortality
and postoperative morbidity related to the use of cardio-
pulmonary bypass, including systemic inflammatory re-
sponse, neurologic complications, global myocardial
ischemia, renal failure, hemodynamic instability, and
lung dysfunction.1,2 However, several prospective
randomized clinical trials (RCTs) comparing off-pump
CABG (OPCAB) and on-pump CABG (ECC) in low-
risk patients3,4 have not been able to demonstrate any
significant reduction in mortality or major postoperative
complications. More recently, some retrospective
observational studies5,6 have shown that in high-risk
patients, OPCAB can reduce operative mortality and
postoperative morbidity compared with ECC, although
1 single-center RCT has shown no difference between
the 2 techniques.7
To further investigate the relative efficacy of ECC and
OPCAB in high-risk patients (euroScore 6), a RCT (on-
off study, clinicaltrials.gov identifier NCT01290952) was
designed to assess the operative, perioperative, and 1-year
clinical outcomes in patients referred for isolated CABG.
The present study reports the primary outcome results.rdiovascular Surgery c Volume 143, Number 3 625
Abbreviations and Acronyms
ARDS ¼ adult respiratory distress syndrome
CABG ¼ coronary artery bypass grafting
ECC ¼ on-pump coronary artery bypass
grafting
MI ¼ myocardial infarction
OPCAB ¼ off-pump coronary artery bypass
grafting
RCT ¼ randomized clinical trial
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Study Design
The on-off study was a multicenter, prospective, randomized, parallel
trial conducted from December 2006 through April 2010 at 7 Italian and
1 Swiss centers. The trial was designed by the principal investigators in co-
operation with the sponsor (Medtronic Italy), approved by the institutional
review board of each participating center, and assessed routinely by a mon-
itoring board. All participants provided written informed consent. The pro-
tocol and consent form were consistent with the Declaration of Helsinki
and all local regulations, as appropriate. The sponsor was involved in the
collection and source verification of the data under the supervision of an
independent clinical events committee composed of 3 physicians with
relevant medical background in the field of cardiac surgery. Moreover,
the independent clinical events committee was in charge of the evaluation
of the correctness of the reported end points. The sponsor’s biostatistician
performed the analyses. The investigators vouch for the completeness and
accuracy of the data collection and analysis. One member of the steering
committee (M.L.) wrote the report, which was reviewed and approved by
all the investigators and the biostatistician.
Center selection was performed to avoid the risk of different expertise
levels.8 All participating surgeons were consultants trained in both ECC
and OPCAB, whose experience was at the plateau of the learning curve
for both techniques. Moreover, at each site, randomization was expertise-
based, allocating enrolled patients to consultants who at a certain point
of their career had decided to use ECC or OPCAB as their prevalent surgi-
cal strategy. These surgeons were declared to be experienced operators in
OPCAB or ECC with a case load of 50 to 100 CABG operations annually
during the previous 5 years.
Patient selection and randomization. All the patients with
a euroScore of 6 or more referred for urgent or elective isolated CABG
were evaluated for enrollment. The exclusion criteria were age of 18 years
or younger, cardiogenic shock requiring emergency surgery and/or preoper-
ative intra-aortic balloon pump, concomitant cardiac or noncardiac surgical
procedures, radiographic evidence of a diseased (porcelain) ascending
aorta, and an inability or unwillingness of the patient to provide consent.
Central randomization assigned the patients in equal proportion to each
arm of the study through a computer-generated random number table.
Randomizationwas stratified by center. Eligible patients were randomly as-
signed to undergo 1 of the 2 treatment options after opening the envelope in
the presence of 2 participating consultants (1 for ECC and 1 for OPCAB
arm) on the day of surgery. Operative planning regarding the number of
coronary anastomoses was done before randomization by the 2 consultants
surgeons (1 for ECC and 1 for OPCAB) assigned to each patient.
A Microsoft Access (Microsoft Office Access 2003; Microsoft, Red-
mond, Wash) database was used to collect and manage the patients’ data.
Surgical technique. Standard median sternotomy was the selected
surgical access to the heart for all patients. General agreement was reached
among the participating centers to perform ECC using normothermia,626 The Journal of Thoracic and Cardiovascular Surgsingle crossclamping of the ascending aorta, and cardioplegic arrest and
to perform OPCAB after the general principles listed in the K.U. Leuven
OPCAB retraining center.9 Anticoagulation was obtained using sodium
heparin at a dose of 3 mg/kg for ECC patients and 1.5 mg/kg for OPCAB
patients. Protaminewas used at a 1:1 ratio for reversal of the heparin effect.
Antifibrinolytic agents were not routinely used. The chosen device for cor-
onary artery stabilization and heart positioning was the Medtronic Octopus
and Starfish (Medtronic, Minneapolis, Minn). These devices were not pro-
vided free of charge by Medtronic but were bought by each participating
center as a part of the routine supply for OPCAB surgery. The type of con-
duits and harvesting technique, type of cardioplegic solution andmethod of
delivery, type of proximal (aortic or composite) and distal (single or se-
quential) anastomoses, intraoperative and postoperative management,
and the medication regimen were chosen according to local clinical
practice.
Study End Points
The primary postoperative end point was a composite of mortality and
major complications comprising myocardial infarction (MI), neurologic
complications, renal failure, adult respiratory distress syndrome (ARDS),
and reoperation for bleeding, occurring within 30 days after surgery. Oper-
ative mortality was defined as death occurring within 30 days of surgery.
MI was defined as the appearance of a new Q wave on the electrocardio-
gram with creatine kinase-myocardial band isoenzyme fraction increase
greater than 100 UI/L and/or more than 10% of the total creatine kinase
level and/or with documented new wall motion abnormalities other than
septal on the echocardiogram. Neurologic complications were defined as
stroke (neurologic deficit lasting>24 hours with positive computed tomog-
raphy findings) or transient ischemic attack (neurologic deficit lasting<24
hours with positive computed tomography findings). Renal failure was de-
fined as an increased plasma creatinine 3 2 associated with urine produc-
tion less than 0.5 mL $ kg1 $ h1 3 12 hours. ARDS was defined as the
presence of tachypnea (respiratory rate>30 breaths/min), bilateral pulmo-
nary infiltrate on chest radiograph, severe hypoxemia (partial pressure of
oxygen in arterial blood/fraction of inspired oxygen ratio<200), need
for positive end-expiratory pressure greater than 5 cm H2O, no evidence
of left ventricular failure (wedge pressure<18 mm Hg), and no other path-
ologic features explaining these findings. Reoperation for bleeding was de-
fined as the need for chest reopening in the presence of more than 500 mL
of blood from chest tubes within the first hour, more than 400mLwithin the
second hour, more than 300 mL within the third hour, or total bleeding
greater than 1000 mL within the fourth hour.
Statistical Analysis
The sample size was estimated, assuming a rate of 20.8% of the com-
bined end point in the ECC group.10 To obtain a reduction of 40% in the
primary end point in the OPCAB group, with a 95% confidence interval
and 80% power, 630 patients (315 per arm) needed to be enrolled. An in-
terim analysis was scheduled at 400 enrolled patients. According to the Po-
cock method,11 the inflation factor to apply to the calculated fixed sample
size to preserve 80% power is 1.1, with a final sample size of 693 patients.
Considering the total significance of P ¼ .05, the a-spending required at
each analysis would be 0.0294. The categorical data are expressed as the
absolute and relative frequency and compared using the chi-square test or
Fisher’s exact test, as adequate. Continuous data are shown as the mean 
standard deviation, if Gaussian, and as the median (25th–75th percentiles)
otherwise. The skewness of continuous distributions was tested using the
Kolmogorov-Smirnov test for 1 sample. Comparisons between normal dis-
tributions were performed using the Student t test for independent samples
and the nonparametricMann-WhitneyU test in the case of skewed distribu-
tions. The primary end point, both composite and split by a single event,
was compared using the Z test or Fisher’s exact test, as appropriate.
According to the interim nature of the present analysis, P< .0294 was
considered statistically significant to reject the null hypothesis.ery c March 2012
FIGURE 1. Flow diagram of on-off study. OPCAB, Off-pump coronary artery bypass; ECC, on-pump coronary artery bypass grafting; AMI, acute myo-
cardial infarction.
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experiencing the primary end point was evaluated using binary logis-
tic regression analysis. A multivariate model was applied to adjust the
results considering the confounding baseline variables, by chance im-
balanced in the groups. Discrimination and calibration of the model
were evaluated using the area under the curve of the receiver operat-
ing characteristic curve and the Hosmer-Lemeshow test, respectively.
Randomization was stratified by center, and the possible center-to-
center differences were evaluated applying a generalized mixed
model, inserting the center as a fixed effect. As per protocol, all anal-
yses were conducted according to the intention-to-treat principle.
P<.05 was considered statistically significant, apart from the primary
objective.
All analyses were performed using StataSE11 for Windows (StataCorp,
College Station, Tex).RESULTS
Study Population
From December 2006 through April 2010, 411 patients
were randomly assigned to elective or urgent ECC (203 pa-
tients) or OPCAB (208 patients; Figure 1). The baseline de-
mographics and clinical characteristics were well balanced
across the 2 groups (Table 1). The mean euroScore was 8,
indicating a population at high surgical risk. OPCAB pa-
tients were significantly older (P ¼ .031). The proportion
of ECC patients with previous MI was significantly larger
(P ¼ .036).The Journal of Thoracic and CaIn-Hospital Outcomes
The number of patients who required conversion to other
treatment was double in ECC group (P ¼. 081; Table 2). A
total of 16 patients (7.9%) crossed-over to OPCAB because
of intraoperative evidence of an excessively calcified as-
cending aorta in 11, mild dilation and thinning of the as-
cending aorta in 2, recent MI in 1, and a decision by the
cardiac anesthetist that considered the patient’s frailty a con-
traindication to ECC after randomization in 2. Also, 8 pa-
tients (3.8%) allocated to OPCAB crossed-over to ECC
because of intraoperative hemodynamic instability in 4, ev-
idence of excessively calcified coronary arteries in 3, and
ventricular tachyarrhythmia in 1.
The operative time was significantly shorter for the OP-
CAB group (P¼ .004). The completeness of the revascular-
ization did not differ significantly between the 2 groups
(P ¼ .241), but the mean number of total and venous coro-
nary anastomoses per patient was significantly greater in the
ECC group (P ¼ .001 and P<.0001, respectively), as was
the difference between the number of performed and
planned distal anastomoses (P<.0001).
Patients’ Clinical Outcome
As reported in Table 3, the intention-to-treat analysis
highlighted a significant difference (unadjusted P ¼ .009,rdiovascular Surgery c Volume 143, Number 3 627
TABLE 1. Preoperative features
Variable OPCAB (n ¼ 208) ECC (n ¼ 203)
Men 146 (70.2) 139 (68.5)
Age (y)
Mean 74 73
Range 69–78 68–77
Current smoker 48 (23.1) 57 (28.1)
Diabetes 89 (42.8) 88 (43.3)
Hypercholesterolemia 141 (67.8) 139 (68.5)
Chronic renal failure 42 (20.2) 28 (13.8)
Hypertension 174 (83.7) 167 (82.3)
Previous CVA 20 (9.6) 20 (9.9)
Peripheral vascular disease 78 (37.5) 71 (35.0)
Carotid stenosis 78 (37.5) 77 (37.9)
COPD 66 (31.7) 51 (25.1)
Previous CABG 1 (0.5) 1 (0.5)
Previous AMI 144 (69.2) 159 (78.3)
NYHA class
I 46 (22.1) 46 (22.8)
II 101 (48.6) 106 (52.5)
III 56 (26.9) 42 (20.8)
IV 5 (2.4) 8 (4.0)
Atrial flutter/fibrillation 12 (5.8) 10 (4.9)
EF
Poor (<30%) 12 (5.8) 4 (2.0)
Moderate (30–50%) 106 (51.0) 115 (56.7)
Good (>50%) 90 (43.3) 84 (41.4)
MR 120 (57.7) 108 (53.2)
Trivial 95 (45.7) 76 (37.4)
Mild 24 (11.5) 30 (14.8)
Moderate 1 (0.5) 2 (1.0)
euroScore
Mean 8 8
Range 7–10 7–9
Unstable angina 120 (57.7) 126 (62.1)
Endovenous antiplatelets 26 (12.5) 22 (10.8)
Endovenous nitrates 39 (18.8) 50 (24.6)
Left main disease 79 (38.0) 83 (40.9)
Mean vessel disease 2.6 (0.6) 2.6 (0.6)
Data presented as number of patients, with percentages in parentheses, unless other-
wise noted. OPCAB, Off-pump coronary artery bypass; ECC, on-pump coronary ar-
tery bypass; CVA, cerebrovascular accident; COPD, chronic obstructive pulmonary
disease; CABG, coronary artery bypass graft; AMI, acute myocardial infarction;
NYHA, New York Heart Association; EF, ejection fraction;MR, mitral regurgitation;
euroScore, European System for Cardiac Operative Risk Evaluation.
TABLE 2. Operative results
Variable
OPCAB
(n ¼ 208)
ECC
(n ¼ 203)
P
value
Crossover 8 (3.8) 16 (7.9) .081
Procedure time (min) 226  59 242  58 .004
Mean number of total anastomoses 3.0  1.1 3.3  1.0 .001
Mean number of arterial anastomoses 1.7  0.9 1.6  0.8 .402
Mean number of venous anastomoses 1.5  1.0 2.0  1.0 <.0001
Coronary anastomoses (n) .010
1 13 (6.3) 5 (2.5)
2 57 (27.4) 38 (18.7)
3 86 (41.3) 83 (40.9)
4 39 (18.8) 54 (26.6)
5 11 (5.3) 21 (10.3)
6 0 2 (1.0)
9 2 (1.0) 0
Performed vs planned distal
anastomoses (n)
<.0001
Mean 0 1
Range 0–1 0–1
Composite graft 69 (33.2) 44 (21.7) .009
ITA graft (n) .335
0 2 (1) 6 (3)
1 173 (83.2) 167 (82.3)
2 33 (15.9) 30 (14.8)
RA graft (n) .807
0 165 (79.3) 163 (80.3)
1 43 (20.7) 40 (19.7)
2 0 0
Endarterectomy 5 (2.4) 4 (2.0) .764
Incomplete revascularization 20 (9.6) 27 (13.3) .241
CPB time (min) 83  58
ACC time (min) 55  35
Coronary shunt 187 (89.9)
Heart positioner 143 (67.8)
Data presented as number of patients, with percentages in parentheses, unless
otherwise noted.OPCAB,Off-pump coronary artery bypass; ECC, on-pump coronary
artery bypass; ITA, internal thoracic artery; RA, radial artery; CPB, cardiopulmonary-
bypass; ACC, aortic crossclamp.
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end point between the ECC (13.3%) and OPCAB (5.8%)
groups. Although not statistically significant, all the compo-
nents of the composite end point (operative mortality, MI,
neurologic complications, renal failure, reoperation for
bleeding) but 1 (ARDS) favored OPCAB patients. The
risk to experience the primary end point was significantly
greater in the ECC than in the OPCAB group (unadjusted
odds ratio, 2.51; 95% confidence interval, 1.23–5.10;
P ¼ .011; adjusted odds ratio, 3.07; 95% confidence inter-
val, 1.32–7.14; P ¼ .009). No differences were found
among the centers (P ¼ .383).628 The Journal of Thoracic and Cardiovascular SurgDISCUSSION
Principal Findings
The on-off study is the first RCT comparing ECC and
OPCAB in high-risk patients (euroScore of 6) demon-
strating the superiority of OPCAB compared with ECC in
the postoperative combined end point (operative mortality,
MI, neurologic complications, renal failure, reoperation for
bleeding).
Comparison With Other Studies
The present on-off study did not confirm the results of
other recently published RCTs that included both with
low-risk12 and high-risk13 patients. The main difference be-
tween our study and the cited RCTs was that the present
study was an expertise-based trial, run by consultants work-
ing in group practices. The surgeons were well qualified, at
the plateau of their learning curve, had a well-documentedery c March 2012
TABLE 3. Primary end point
End point
ECC
(n ¼ 203)
OPCAB
(n ¼ 208)
Unadjusted
P value
Adjusted
P value
Composite 27 (13.3) 12 (5.8) .009 .010*
Operative mortality 7 (3.4) 4 (1.9) .376 .379
Myocardial infarction 6 (3.0) 4 (1.9) .539 .514
Stroke 1 (0.5) — .494 .995
Renal failure 10 (4.9) 5 (2.4) .173 .149
Reoperation for bleeding 7 (3.4) 3 (1.4) .216 .115
ARDS — 1 (0.5) 1.000 .995
Data presented as number of patients, with percentages in parentheses. OPCAB, Off-
pump coronary artery bypass; ECC, on-pump coronary artery bypass; ARDS, adult
respiratory distress syndrome. *Hosmer-Lemeshow ¼ 0.978; area under the curve,
0.64; 95% confidence interval, 0.56–0.73; P ¼ .003.
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preferred, inwhich they had expertise and that they used rou-
tinely during their daily practice (ECC or OPCAB). In the
Randomized On/Off Bypass trial,12 some of the participat-
ing surgeons were trainees and were required to document
at least 20 OPCAB procedures to participate in the study.
In general, the success of a surgical techniques improves
with much more extensive experience than that required in
the Randomized On/Off Bypass trial. An observational
study of 5678 isolated CABG procedures14 showed a pro-
gressive decrease in the observed and adjusted-risk mortal-
ity during the first 4 years of independent practice.
Considering that OPCAB is recognized as more technically
demanding than ECC, we can argue that in the Randomized
On/Off Bypass trial, surgeons could not have been ade-
quately trained. This has also been witnessed by the high
number of procedural crossovers: 137 (12.4%) in the OP-
CAB group and 40 (3.6%) in the ECC group (P<.001).
In contrast, during the present on-off study, the number of
procedural crossovers was 8 (3.8%) in the OPCAB group
and 16 (7.9%) in the ECC group (P ¼ .081). The Best By-
pass Surgery (BBS) trial13 better addressed the issue of the
lack of expertise. In that single-center study, OPCAB had
been performed routinely for 2 years before the launch of
the trial and each of the 3 participating surgeons performed
at least 50% of their CABG procedures using OPCAB.
However, it was not designed as an expertise-based trial
(the 3 participating surgeons performed both ECC and OP-
CAB during the study), and the surgeons were aware of
which procedures they performed and could have uncon-
sciously biased the trial findings, favoring the procedure
they believed might give better outcomes. This was not pos-
sible during the present on-off study, because surgeons could
only be unconsciously biased toward the procedure they pre-
ferred, in which they had greater experience, and which they
used during both the trial and their daily practice.
Surgical Procedure and Outcome
In the present on-off study, there was a remarkably low
rate of neurologic events in both the ECC (0.5%) andThe Journal of Thoracic and CaOPCAB (0%) groups (P ¼ .494). This finding can be re-
lated to the relatively frequent use of composite grafts
(21.7% in the ECC group and 33.2% in the OPCAB group,
P ¼ .009), with single clamping of the ascending aorta in
ECC patients and a 7.9% (n ¼ 16) conversion rate from
ECC to OPCAB (n ¼ 11) for a severely diseased ascending
aorta. All these factors contributed to reducing ascending
aorta manipulation. The absence of neurologic events in
OPCAB patients and the low rate of procedural conversion
to ECC are testament to the hemodynamic stability during
OPCAB. The use of coronary shunts (89.9%) and a heart
positioner (67.8%) was fundamental in achieving this re-
sult. Hemodynamic stability and the avoidance of cardio-
pulmonary bypass with nonpulsatile flow could also
explain the lower incidence of postoperative renal failure
in the OPCAB group (2.4% vs 4.9%, P ¼ .173). Reopera-
tion for bleeding was lower, but the difference was not sta-
tistically significant, in the OPCAB group. In contrast, the
incidence of blood transfusion was significantly greater
among ECC patients (65.5% vs 50.5%, P¼ .002). The pro-
cedure time was significantly shorter in the OPCAB group
(P ¼ .004) but with a significantly lower mean number of
distal anastomoses per patient (P ¼ .001). However, the in-
completeness of revascularization (determined by the num-
ber of grafts planned vs the number performed) was almost
identical (P ¼ .241), as was the mean number of coronary
vessel disease (Table 1). A possible explanation is that dur-
ing ECC, the surgeons decided to perform bypass on coro-
nary arteries they had not planned preoperatively, such as
was shown by the significant difference between the number
of performed and planned distal anastomoses (P<.0001).
Implications
Coronary patients tend to be older and more ill, with high
frailty index, a high predicted risk of mortality, and complex
3-vessel coronary artery disease. This picture is peculiar to
the group of patients requiring surgical treatment and who
will be a part of the practice of cardiac surgeons in the com-
ing years. Because they are fragile, high-risk patients, their
surgical treatment should be less stressful for the whole
body. In the United States, there is already a national trend15
that favors OPCAB for elderly and frail patients, in the be-
lief that cardiopulmonary bypass could be dangerous for
them. This trend is based on the results from several retro-
spective analyses of large databases that have clearly shown
the reduced risk-adjusted mortality after OPCAB compared
with after ECC.16,17 The present on-off study has corrobo-
rated and completed the results of these studies. It is the first
RCT to show OPCAB to be safer than ECC at 30 days for
high-risk patients. The primary composite end point (oper-
ative mortality, MI, neurologic complications, renal failure,
reoperation for bleeding) favored OPCAB compared with
ECC in the intention-to-treat analysis (unadjusted
P ¼ .009, adjusted P ¼ .010). A trend was found towardrdiovascular Surgery c Volume 143, Number 3 629
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P ¼ .081), because of the study design that reduced proce-
dural crossovers resulting from technical problems. The
greater rate of conversion to other treatment in the ECC
group was not related to the surgical technique but mainly
to anatomic reasons, such as a severely diseased ascending
aorta, a frequent finding in this patient population.
Study Limitations
The present on-off was a sponsored study. However, to re-
duce the risk of bias, the outcomes were assessed by an in-
dependent clinical events committee composed of 3
physicians with a relevant medical background in the field
of cardiac surgery (whowere unaware of the allocated treat-
ment). The sponsor’s biostatistician performed blinded anal-
yses of the primary end point, receiving data with a coded
indication of the randomized group assigned to each patient.
CONCLUSIONS
In high-risk patients (euroScore of 6), OPCAB reduces
early mortality and morbidity (MI, neurologic complica-
tions, renal failure, reoperation for bleeding, ARDS) com-
pared with ECC.
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Dr Joseph F. Sabik (Cleveland, Ohio). I would like to congrat-
ulate Dr Lemma and colleagues on a fine presentation and study
and thank them for providing me with a copy of their manuscript
and presentation in advance of the meeting.
I have 3 questions. In this study, 411 patients were entered, how-
ever, you do not tell us how many patients were screened and, of
those screened, what percentage were eligible and, of those eligi-
ble, what percentage were actually enrolled in the study. This in-
formation is important in deciding what percentage of patients
undergoing coronary surgery this study is applicable to and to
whether it is representative of most patients with a euroScore of
6 or higher. Can you provide this information?
My second question is, the study was designed as an expertise-
based randomized controlled trial. In other words, as you
explained, if a patient was randomized to off-pump surgery, his sur-
gery was performed by an expert in off-pump surgery, and if the pa-
tientwas randomized toon-pumpsurgery, his surgerywasperformed
by an expert in on-pump surgery. Therefore, in addition to being ran-
domized to 2 different procedures, the patients were randomized to 2
different groups of surgeons. How can we determine whether the
better outcomes observed in the off-pump patients were because of
off-pump surgery being better or the possibility that the off-pump
surgeonswere better surgeons and therefore their patients did better?
My final question has to do with revascularization. Similar to
other studies comparing on- and off-pump surgery, fewer bypass
grafts were performed in the off-pump surgery group. This is par-
ticularly alarming, because this study is an expertise-based study.
This suggests that off-pump surgery, even in expert hands, might
be a less-effective revascularization strategy than on-pump sur-
gery. Understanding the importance of the completeness of revas-
cularization on long-term outcomes, do the better early outcomes
in off-pump surgery justify the potential long-term risk?
Thank you very much.
Dr Lemma. Thank you very much, Dr Sabik, for your com-
ments. About your first question, we do not know precisely how
many patients were screened and how many were eligible as a di-
rect consequence of the study design. The on-off study was an ex-
pertise-based trial run by consultants working in group practices.
This means that we had plenty of screened and eligible patients
but only a few of them could be randomized because the study pro-
tocol required the simultaneous presence of 2 consultants for the
same patient, 1 an expert in off-pump and 1 an expert in on-
pump surgery at the moment of envelope opening in the operating
room. In a few hospitals, these data were not always recorded so I
can’t give you figures. This is also the reason the study took
roughly 4 years to be completed.ery c March 2012
Lemma et al Acquired Cardiovascular Disease
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DDr Sabik. Can I ask a follow-up. Do you have an idea of what
percentage of patients undergoing surgery have a euroScore
greater than 6? Is it 5%, 10%, 20%?
Dr Lemma. I don’t know precisely the figure how many pa-
tients had a euroScore greater than 6 among the screened and eli-
gible patients. I can tell you that the average euroScore was 8 in
both groups, on-pump and off-pump patients.
About the question related to the number of distal anastomoses,
this is an interesting point in the sense that we had 3.0 distal anas-
tomoses in the off-pump group and 3.3 in the on-pump group.
However, if you consider the difference between the planned ver-
sus performed distal anastomoses, in the off-pump group, the num-
ber of distal anastomoses performed was equal to the number of
distal anastomoses predicted, but in the on-pump group, the num-
ber of distal anastomoses performed was greater than the number
of distal anastomoses predicted. Thus, it seems that there was an
attitude in the on-pump group to perform more distal anastomoses
than predicted before the operation.
And the last question was?
Dr Sabik. Something we don’t often see in surgery is an exper-
tise-based trial. It obviously adds the confounder of different sur-
gical groups.
Dr Lemma. Well, I would see the problem the other way
around in the sense that expertise-based studies are important be-
cause only an expert surgeon can precisely apply a given surgical
technique. Moreover, in an expertise-based study, you do not have
a surgeons who can be consciously or unconsciously biased toward
a treatment, because they do believe the treatment they apply is the
best. If you consider other prospective randomized trials, such as
the Best Bypass Surgery study published recently in the journal
Circulation, they enrolled 3 surgeons who performed both on-
pump and off-pump surgery. However, we can’t imagine that
they were neutral toward these 2 procedures. For sure, they pre-
ferred 1 of these 2, and so they could have consciously or uncon-
sciously been biased toward 1 of these 2 treatments. In our study,
the surgeons couldn’t be biased, either consciously or uncon-
sciously, toward on-pump or off-pump surgery because they be-
lieved the treatment they applied was the best one.
Dr Sabik. Thank you.
Dr Lokeswara Rao Sajja (Hyderabad, India). I congratulate
Dr Lemma for an excellently designed and executed study. I
have a couple of questions. In your study, was the preoperative se-
rum creatinine level comparable between the 2 groups? Because
even a marginal increase in the preoperative creatinine in 1 group
can lead to an increased incidence of postoperative renal failure
in that group. I also find that in the intention-to-treat analysis, there
was no significant difference in the incidence of renal failure be-
tween the ECC group and the OPCAB group, but the in on-treat-
ment analysis, there was a significant difference. Is this
difference due to the conversion of the cases fromOPCAB to ECC?
Dr Lemma. Thank you for your question. There was no differ-
ence between the 2 groups in the renal function. The only differences
among the preoperative clinical characteristics were in age—we had
older patients in the off-pump group—and myocardial infarction, of
which we had a greater incidence in the on-pump group.
After on-treatment analysis, which means considering cross-
overs, renal function became statistically significant, per se. This
probably means that the hemodynamic stability of off-pumpThe Journal of Thoracic and Casurgery was ideal to preserve renal function, but in the on-pump
group, the continuous flow due to the pump probably decreased
the function of the patient with preoperative borderline renal
function.
Dr Sajja. It is presented that reoperation for postoperative
bleeding was significantly greater in the ECC group. Was the pro-
tocol to stop antiplatelet drug therapy uniform in both the groups?
Were the patients on single antiplatelet or dual-antiplatelet therapy
before the patients were subjected to surgery?
Dr Lemma. The antiplatelet protocol was the same in both
groups. The patients usually stopped antiplatelets at least 5 days
before surgery.
Dr John D. Puskas (Atlanta, Ga). Dr Lemma, I congratulate
you on a landmark study in off-pump bypass, a subject near and
dear to my own heart. It is interesting to see this expertise-based
randomization strategy. I do believe it is an important way to
look at this problem of comparing off-pump and on-pump bypass.
Certainly, the failure to do that sort of equivalence of expertise in
both surgical groups in the Randomized On/Off Bypass trial was
a fundamental flaw of that trial, and you have avoided that with
your design. I have 3 questions.
You commented on the completeness of revascularization, that
is, the number of grafts performed versus planned having been dif-
ferent between the groups. Was the completeness of revasculariza-
tion accomplished in the lateral wall in the off-pump group? That
is where the rubber hits the road. Were your surgeons able to graft
the lateral wall effectively and completely in the off-pump group?
Was the extra graft or 0.3 of a graft in the on-pump group sort of
a gratuitous extra diagonal graft by a motivated team of on-
pump surgeons?
The second question, was the use of arterial conduits similar be-
tween the groups?
Finally, can you share with us any information about the length
of stay or cost comparisons between these 2 groups?
Again, congratulations on a terrific study.
Dr Lemma.Well, I don’t have an answer for your last question
in the sense that a cost-comparison analysis was not planned in the
study design, and the length of stay was a part of secondary end
point analysis. Thus, these data will be analyzed in conjunction
with 1 year of follow-up. About the question of whether in the
off-pump group, also the obtuse marginal branch was easily by-
passed, the answer is yes. If you consider the data, 70% of surgeons
routinely used a heart positioner and 90% routinely used intracoro-
nary shunts. This means that according to the principles espoused
by Paul Sergeant in his Web site related to the teachable compo-
nents of off-pump surgery, the surgeons were able to maintain
a perfect hemodynamic stability throughout the operation without
any problem bypassing the obtuse marginal branch.
And the second question, Dr Puskas, was?
Dr Puskas. Arterial grafting. Was the use of arterial conduits
similar between the groups and what was the use of arterial
conduits?
Dr Lemma. No difference was found between the use of arte-
rial conduits in the 2 groups, neither as number nor as type. The
only difference was in the number of venous grafts, it was greater
in the on-pump group, as you said probably a sort of gratuitous ex-
tra graft by a motivated team of on-pump surgeons.
Dr Puskas. Thank you.rdiovascular Surgery c Volume 143, Number 3 631
